Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Banking
  • Finance
  • Nyse
  • Stocks
  • Yacht Buyer
  • Loans
ncarol.com

SafeBreak® Vascular Cleared for Pediatrics
ncarol.com/10222999

Trending...
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Caraline Skincare's Gentle Glow Cleansing Oil Named Finalist for Best Face Cleanser at the 2026 CertClean Clean Beauty Awards​
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on ncarol.com
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
  • Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry
  • Best Book Publishing Company for Aspiring Authors
  • Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • AKG To Demonstrate New Digital E-catalog Experience Daily At CONEXPO CON/AGG 2026
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
  • STEM For Kids Launches Root Protocol™: A Human Bridge for Gen Alpha's Digital Curiosity Crisis
  • Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
  • 2026 Pre-Season Testing Confirms a Two-Tier Grid as Energy Management Defines Formula 1's New Era
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
  • Postmortem Pathology Expands Independent Autopsy Services Across Colorado
  • $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • Mecpow M1: A Safe & Affordable Laser Engraver Built for Home DIY Beginners
  • CrashStory.com Launches First Colorado Crash Data Platform Built for Victims, Not Lawyers
  • Inkdnylon Earns BBB Accreditation for Verified Business Integrity
  • Josh Stout "The Western Project"
  • Open House Momentum Builds at Heritage at South Brunswick
  • A Celebration of Visibility, Voice and Excellence: The 57th NAACP Image Awards Golf Invitational, Presented by Wells Fargo, A PGD Global Production
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 109
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community - 108
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • Still Using Ice? FrostSkin Reinvents Hydration
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount

Similar on ncarol.com

  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute